Zura Bio Limited (94E.F)

EUR 1.26

(0.8%)

Operating Income Summary of Zura Bio Limited

  • Zura Bio Limited's latest annual operating income in 2023 was -62.63 Million USD , N/A from previous year.
  • Zura Bio Limited's latest quarterly operating income in 2024 Q2 was -11.75 Million USD , down -40.34% from previous quarter.
  • Zura Bio Limited reported an annual operating income of -2.67 Million USD in 2022, down 0.0% from previous year.
  • Zura Bio Limited reported an annual operating income of -1.09 Million USD in 2021, N/A from previous year.
  • Zura Bio Limited reported a quarterly operating income of -8.37 Million USD for 2024 Q1, up 22.61% from previous quarter.
  • Zura Bio Limited reported a quarterly operating income of -10.18 Million USD for 2023 Q3, up 69.95% from previous quarter.

Annual Operating Income Chart of Zura Bio Limited (2023 - 2021)

Created with Highcharts 11.1.0YearsOperating Income20212021.22021.42021.62021.820222022.22022.42022.62022.82023-70000000 EUR-60000000 EUR-50000000 EUR-40000000 EUR-30000000 EUR-20000000 EUR-10000000 EUR0 EUR

Historical Annual Operating Income of Zura Bio Limited (2023 - 2021)

Year Operating Income Operating Income Growth
2023 -62.63 Million USD N/A
2022 -2.67 Million USD 0.0%
2021 -1.09 Million USD N/A

Peer Operating Income Comparison of Zura Bio Limited

Name Operating Income Operating Income Difference
BioNTech SE 690.4 Million EUR 109.073%
CureVac N.V. -274.2 Million EUR 77.157%
Biotest Aktiengesellschaft 143.5 Million EUR 143.65%
Biotest Aktiengesellschaft 143.5 Million EUR 143.65%
BRAIN Biotech AG -6.71 Million EUR -832.807%
Formycon AG -369 Thousand EUR -16875.068%
Heidelberg Pharma AG -21.2 Million EUR -195.326%
Medigene AG -16.14 Million EUR -287.875%